These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6478466)

  • 21. Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
    Myerburg RJ; Kessler KM; Kiem I; Pefkaros KC; Conde CA; Cooper D; Castellanos A
    Circulation; 1981 Aug; 64(2):280-90. PubMed ID: 7249296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes.
    Bhandari AK; Au PK; Rahimtoola SH
    Can J Cardiol; 1986; 2(1):6-9. PubMed ID: 2420424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysis.
    DiCarlo LA; Susser F; Winston SA
    Am Heart J; 1990 Dec; 120(6 Pt 1):1347-55. PubMed ID: 1978977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferential effect of procainamide on the reentrant circuit of ventricular tachycardia.
    Kay GN; Epstein AE; Plumb VJ
    J Am Coll Cardiol; 1989 Aug; 14(2):382-90. PubMed ID: 2754127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
    Grimm W; Cho JG; Marchlinski FE
    J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease.
    German LD; Packer DL; Bardy GH; Gallagher JJ
    Am J Cardiol; 1983 Dec; 52(10):1202-7. PubMed ID: 6650408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
    Trappe HJ; Klein H; Lichtlen PR
    Z Kardiol; 1987 Oct; 76(10):630-4. PubMed ID: 3687165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of procainamide on induced ventricular tachycardia.
    Engel TR; del Gonzalez A; Meister SG; Franki WS
    Clin Pharmacol Ther; 1978 Sep; 24(3):274-82. PubMed ID: 688720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
    Breithardt G; Borggrefe M; Yeh HL; Seipel L
    Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol.
    Buxton AE; Waxman HL; Marchlinski FE; Josephson ME
    Am J Cardiol; 1984 Mar; 53(6):738-44. PubMed ID: 6702622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
    Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE
    Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic action of bethanidine.
    Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Wynn J; Keren G; Miura DS
    Am J Cardiol; 1984 Aug; 54(3):343-6. PubMed ID: 6465015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Successful treatment of stress-induced therapy refractory ventricular tachycardia with verapamil].
    Kühlkamp V; Kohler S; Seipel L
    Z Kardiol; 1989 Jun; 78(6):405-7. PubMed ID: 2474223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Termination of ventricular tachycardia: role of tachycardia cycle length.
    Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME
    Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
    Friehling TD; Lipshutz H; Marinchak RA; Stohler JL; Kowey PR
    Am J Cardiol; 1990 Jun; 65(20):1328-33. PubMed ID: 2343820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectopic ventricular tachycardia sensitive to calcium antagonists in acute myocardial infarction in dogs.
    Miyazaki T; Ogawa S; Sakurai K; Mori H; Yamazaki H; Nakamura Y
    Am J Cardiol; 1985 Apr; 55(8):1085-90. PubMed ID: 3984871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic sustained ventricular tachycardia responsive to verapamil: clinical electrocardiographic and electrophysiologic considerations.
    Kasanuki H; Ohnishi S; Tanaka E; Hirosawa K
    Jpn Circ J; 1986 Jan; 50(1):109-18. PubMed ID: 3702031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.
    Sung RJ; Keung EC; Nguyen NX; Huycke EC
    J Clin Invest; 1988 Mar; 81(3):688-99. PubMed ID: 2893808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease.
    Buxton AE; Marchlinski FE; Doherty JU; Cassidy DM; Vassallo JA; Flores BT; Josephson ME
    Am J Cardiol; 1984 Nov; 54(8):997-1002. PubMed ID: 6496364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.